CollPlant Biotechnologies (CLGN) Receivables - Net (2018 - 2025)

CollPlant Biotechnologies' Receivables - Net history spans 7 years, with the latest figure at $1000.0 for Q4 2025.

  • For Q4 2025, Receivables - Net fell 99.33% year-over-year to $1000.0; the TTM value through Dec 2025 reached $1000.0, down 99.33%, while the annual FY2025 figure was $1000.0, 99.33% down from the prior year.
  • Receivables - Net reached $1000.0 in Q4 2025 per CLGN's latest filing, down from $150000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $270000.0 in Q4 2021 to a low of $1000.0 in Q4 2025.
  • Average Receivables - Net over 4 years is $107500.0, with a median of $79500.0 recorded in 2022.
  • Peak YoY movement for Receivables - Net: tumbled 67.47% in 2021, then plummeted 99.33% in 2025.
  • A 4-year view of Receivables - Net shows it stood at $270000.0 in 2021, then plummeted by 96.67% to $9000.0 in 2022, then skyrocketed by 1566.67% to $150000.0 in 2024, then tumbled by 99.33% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Receivables - Net are $1000.0 (Q4 2025), $150000.0 (Q4 2024), and $9000.0 (Q4 2022).